Patents by Inventor Alamelu Sundaresan
Alamelu Sundaresan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20140227730Abstract: The present disclosure provides methods for identifying candidate compounds having bone anti-resorption activity or bone pro-formation activity. The methods involve the use of ex vivo-derived mineralized three-dimensional bone constructs. The bone constructs are obtained by culturing osteoblasts and osteoclast precursors under randomized gravity vector conditions in the presence of the candidate compound. Preferably, the randomized gravity vector conditions are obtained using a low shear stress rotating bioreactor, such as a High Aspect Ratio Vessel (HARV) culture system.Type: ApplicationFiled: June 14, 2012Publication date: August 14, 2014Applicant: OSTEOSPHERE, LLCInventors: Mark S.F. Clarke, Alamelu Sundaresan, Mark Brinker
-
Patent number: 8557576Abstract: The present disclosure provides ex vivo-derived mineralized three-dimensional bone constructs. The bone constructs are obtained by culturing osteoblasts and osteoclast precursors under randomized gravity vector conditions. Preferably, the randomized gravity vector conditions are obtained using a low shear stress rotating bioreactor, such as a High Aspect Ratio Vessel (HARV) culture system. The bone constructs of the disclosure have utility in physiological studies of bone formation and bone function, in drug discovery, and in orthopedics.Type: GrantFiled: May 17, 2010Date of Patent: October 15, 2013Assignees: The United States of America as represented by the National Aeronautics and Space Administration, University of Houston, Universities Space Research AssociationInventors: Mark S. F. Clarke, Alamelu Sundaresan, Neal R. Pellis
-
Patent number: 8506982Abstract: The present disclosure provides colloidal bone graft compositions comprising a plurality of mineralized three-dimensional bone constructs, a polymerizable biocompatible matrix, an osteoblast differentiation agent, and at least one osteoblast mineralization agent. The colloidal bone graft compositions of the disclosure are used to perform bone grafts in human or animal patients.Type: GrantFiled: November 14, 2008Date of Patent: August 13, 2013Assignee: Osteosphere, LLCInventors: Alamelu Sundaresan, Mark S. F. Clarke, Mark Brinker
-
Publication number: 20120058557Abstract: The present disclosure provides ex-vivo derived mineralized three-dimensional bone constructs. The bone constructs are obtained by culturing osteoblasts and osteclast precursors under randomized gravity vector conditions. Preferably, the randomized gravity vector conditions are obtained using a low shear stress rotating bioreactor, such as a High Aspect Ratio Vessel (HARV) culture system. The bone constructs of the disclosure have utility in physiological studies of bone formation and bone function, in drug discovery, and in orthopedics.Type: ApplicationFiled: November 11, 2011Publication date: March 8, 2012Inventors: Mark S.F. Clarke, Alamelu Sundaresan, Neal R. Pellis
-
Patent number: 8076136Abstract: The present disclosure provides ex vivo-derived mineralized three-dimensional bone constructs. The bone constructs are obtained by culturing osteoblasts and osteoclast precursors under randomized gravity vector conditions. Preferably, the randomized gravity vector conditions are obtained using a low shear stress rotating bioreactor, such as a High Aspect Ratio Vessel (HARV) culture system. The bone constructs of the disclosure have utility in physiological studies of bone formation and bone function, in drug discovery, and in orthopedics.Type: GrantFiled: March 29, 2007Date of Patent: December 13, 2011Assignees: The United States of America as represented by the United States National Aeronautics and Space Administration, University of Houston, Universities Space Research AssociationInventors: Mark S. F. Clarke, Alamelu Sundaresan, Neal R. Pellis
-
Publication number: 20110217352Abstract: The present disclosure provides colloidal bone graft compositions comprising a plurality of mineralized three-dimensional bone constructs, a polymerizable biocompatible matrix, an osteoblast differentiation agent, and at least one osteoblast mineralization agent. The colloidal bone graft compositions of the disclosure are used to perform bone grafts in human or animal patients.Type: ApplicationFiled: November 14, 2008Publication date: September 8, 2011Applicant: OSTEOSPHERE, LLCInventors: Alamelu Sundaresan, Mark S.F. Clarke, Mark Brinker
-
Publication number: 20110129866Abstract: The present disclosure provides methods for identifying candidate compounds having bone anti-resorption activity or bone pro-formation activity. The methods involve the use of ex vivo-derived mineralized three-dimensional bone constructs. The bone constructs are obtained by culturing osteoblasts and osteoclast precursors under randomized gravity vector conditions in the presence of the candidate compound. Preferably, the randomized gravity vector conditions are obtained using a low shear stress rotating bioreactor, such as a High Aspect Ratio Vessel (HARV) culture system.Type: ApplicationFiled: November 14, 2008Publication date: June 2, 2011Applicant: OSTEOSPHERE, LLCInventors: Mark S.F. Clarke, Alamelu Sundaresan, Mark Brinker
-
Publication number: 20110091862Abstract: The present disclosure provides methods for producing human osteogenic cell lines in which HLA Class I expression is absent or reduced. The resulting osteogenic cells can then be used, for example, to form mineralized three-dimensional bone constructs which can be used, for example, in bone grafting procedures. The lack of HLA Class I expression in the cells of the mineralized three-dimensional bone constructs reduces or eliminates the potential for host-graft rejection.Type: ApplicationFiled: November 13, 2008Publication date: April 21, 2011Applicant: OSTEOSPHERE, LLCInventors: Mark S.F. Clarke, Mark Brinker, Alamelu Sundaresan
-
Publication number: 20110086080Abstract: The present disclosure provides ex vivo-derived human demineralized bone matrix. The bone matrix is produced using mineralized three-dimensional bone constructs. The bone constructs are obtained by culturing osteoblasts and osteoclast precursors under randomized gravity vector conditions. Preferably, the randomized gravity vector conditions are obtained using a low shear stress rotating bioreactor, such as a High Aspect Ratio Vessel (HARV) culture system. The ex vivo-derived human demineralized bone matrix of the disclosure can be used in, for example, orthopedic and periodontal procedures.Type: ApplicationFiled: November 14, 2008Publication date: April 14, 2011Applicant: OSTEOSPHERE, LLCInventors: Mark S.F. Clarke, Mark Brinker, Alamelu Sundaresan
-
Publication number: 20110082549Abstract: The present disclosure provides ex vivo-derived mineralized three-dimensional bone constructs. The bone constructs are obtained by culturing osteoblasts under randomized gravity vector conditions. Preferably, the randomized gravity vector conditions are obtained using a low shear stress rotating bioreactor, such as a High Aspect Ratio Vessel (HARV) culture system. The bone constructs of the disclosure have utility in physiological studies of bone formation and bone function, in drug discovery, and in orthopedics.Type: ApplicationFiled: February 2, 2009Publication date: April 7, 2011Applicant: OSTEOSPHERE, LLCInventors: Mark S.F. Clarke, Mark R. Brinker, Alamelu Sundaresan
-
Publication number: 20110081682Abstract: The present disclosure provides methods for producing Bone Morphogenetic Proteins (BMPs). The BMPs are produced using ex vivo-derived mineralized three-dimensional bone constructs of varying degrees of maturity and mineralization. The bone constructs are obtained by culturing osteoblasts and osteoclast precursors under randomized gravity vector conditions whereupon the bone constructs secrete BMPs into the culture medium. Culture medium is periodically removed from the bone construct culture, and the BMPs are purified from the removed culture medium.Type: ApplicationFiled: November 13, 2008Publication date: April 7, 2011Applicant: OSTEOSPHERE, LLCInventors: Mark Brinker, Mark S.F. Clarke, Alamelu Sundaresan
-
Publication number: 20100227358Abstract: The present disclosure provides ex vivo-derived mineralized three-dimensional bone constructs. The bone constructs are obtained by culturing osteoblasts and osteoclast precursors under randomized gravity vector conditions. Preferably, the randomized gravity vector conditions are obtained using a low shear stress rotating bioreactor, such as a High Aspect Ratio Vessel (HARV) culture system. The bone constructs of the disclosure have utility in physiological studies of bone formation and bone function, in drug discovery, and in orthopedics.Type: ApplicationFiled: May 17, 2010Publication date: September 9, 2010Applicant: OSTEOSPHERE, LLCInventors: Mark S.F. Clarke, Alamelu Sundaresan, Neal R. Pellis
-
Publication number: 20090061479Abstract: The present disclosure provides ex vivo-derived mineralized three-dimensional bone constructs. The bone constructs are obtained by culturing osteoblasts and osteoclast precursors under randomized gravity vector conditions. Preferably, the randomized gravity vector conditions are obtained using a low shear stress rotating bioreactor, such as a High Aspect Ratio Vessel (HARV) culture system. The bone constructs of the disclosure have utility in physiological studies of bone formation and bone function, in drug discovery, and in orthopedics.Type: ApplicationFiled: March 29, 2007Publication date: March 5, 2009Inventors: Mark S.F. Clarke, Alamelu Sundaresan, Neal R. Pellis